Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

AeRang Kim

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
JCO Precision Oncology|November 29, 2022
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood CancerLorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA FragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, et al.
JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
Neuro-Oncology|July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensusPeter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Nature Medicine|June 23, 2022
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J Church, Laura B Corson, Pei-Chi Kao, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
JCO Precision Oncology|November 29, 2022
Rare FGFR Oncogenic Alterations in Sequenced Pediatric Solid and Brain Tumors Suggest FGFR Is a Relevant Molecular Target in Childhood CancerLorena Lazo De La Vega, Hannah Comeau, Sarah Sallan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2024
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA FragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, et al.
JCO Precision Oncology|December 29, 2021
Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid TumorJaclyn Schienda, Alanna J Church, Laura B Corson, et al.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Early detection of malignant and pre-malignant peripheral nerve tumors using cell-free DNA fragmentomicsR Taylor Sundby, Jeffrey J Szymanski, Alexander Pan, et al.
JCO Precision Oncology|March 30, 2023
Clinical Targeted Next-Generation Panel Sequencing Reveals <i>MYC</i> Amplification Is a Poor Prognostic Factor in OsteosarcomaAmanda E Marinoff, Liam F Spurr, Christina Fong, et al.
Neuro-Oncology|July 5, 2022
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensusPeter M K de Blank, Andrea M Gross, Srivandana Akshintala, et al.
Nature Medicine|June 23, 2022
Molecular profiling identifies targeted therapy opportunities in pediatric solid cancerAlanna J Church, Laura B Corson, Pei-Chi Kao, et al.
Pageof 7